Literature DB >> 31720985

HPV vaccination in Japan: can educational intervention promote a father's intention to encourage his daughter's vaccination?

Ai Miyoshi1, Tsuyoshi Takiuchi2, Tadashi Kimura1.   

Abstract

BACKGROUND: HPV vaccines are well known to prevent several devastating HPV-associated cancers-when administered before sexual activity begins. We have previously found that mothers in Japan play an important role in a young girl's vaccination decision-making, and that educational intervention with the mothers positively changed their attitude towards the HPV vaccine. The role of fathers is still unclear. We report here similar effects can be achieved by an educational intervention with the fathers.
METHOD: We conducted an online survey of 1648 Japanese fathers as having 13-18 year-old daughters. In this group, 1450 fathers had HPV-unvaccinated daughters. Roughly half, 721, were supplied an educational sheet concerning cervical cancer, which included information regarding the safety and efficacy of the HPV vaccine, the other 729 did not receive the sheet. Afterwards, a self-administered questionnaire obtained information from both groups of fathers. We evaluated their attitudes and intentions to inoculate their daughters and willingness to be associated with the vaccination decision-making process.
RESULTS: Paternal education with an information sheet was associated with an increased odds ratio for changing the father's attitude in a positive direction, but it was not associated with improving the father's intention to their have their daughters inoculated, nor the father's willingness to be associated with the decision-making process.
CONCLUSION: While educational intervention can promote a father's positive attitude towards HPV vaccination, it is ineffective at promoting a positive intention to follow through to inoculate their daughters or improving their willingness to assist in the decision-making process.

Entities:  

Keywords:  Educational intervention with the fathers; Father’s attitude; Father’s intention; HPV vaccination

Year:  2019        PMID: 31720985     DOI: 10.1007/s10147-019-01575-y

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  6 in total

1.  Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

Authors:  Matti Lehtinen; Jorma Paavonen; Cosette M Wheeler; Unnop Jaisamrarn; Suzanne M Garland; Xavier Castellsagué; S Rachel Skinner; Dan Apter; Paulo Naud; Jorge Salmerón; Song-Nan Chow; Henry Kitchener; Júlio C Teixeira; James Hedrick; Genara Limson; Anne Szarewski; Barbara Romanowski; Fred Y Aoki; Tino F Schwarz; Willy A J Poppe; Newton S De Carvalho; Maria Julieta V Germar; Klaus Peters; Adrian Mindel; Philippe De Sutter; F Xavier Bosch; Marie-Pierre David; Dominique Descamps; Frank Struyf; Gary Dubin
Journal:  Lancet Oncol       Date:  2011-11-08       Impact factor: 41.316

2.  Japan's failure to vaccinate girls against human papillomavirus.

Authors:  Yutaka Ueda; Takayuki Enomoto; Masayuki Sekine; Tomomi Egawa-Takata; Akiko Morimoto; Tadashi Kimura
Journal:  Am J Obstet Gynecol       Date:  2014-11-27       Impact factor: 8.661

3.  Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age.

Authors:  Abbey B Berenson; Tabassum H Laz; Jacqueline M Hirth; Christine J McGrath; Mahbubur Rahman
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses.

Authors:  Marie-Pierre David; Koen Van Herck; Karin Hardt; Fabian Tibaldi; Gary Dubin; Dominique Descamps; Pierre Van Damme
Journal:  Gynecol Oncol       Date:  2009-02-12       Impact factor: 5.482

5.  Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

Authors:  J Paavonen; P Naud; J Salmerón; C M Wheeler; S-N Chow; D Apter; H Kitchener; X Castellsague; J C Teixeira; S R Skinner; J Hedrick; U Jaisamrarn; G Limson; S Garland; A Szarewski; B Romanowski; F Y Aoki; T F Schwarz; W A J Poppe; F X Bosch; D Jenkins; K Hardt; T Zahaf; D Descamps; F Struyf; M Lehtinen; G Dubin
Journal:  Lancet       Date:  2009-07-06       Impact factor: 79.321

6.  Development of an efficient strategy to improve HPV immunization coverage in Japan.

Authors:  Asami Yagi; Yutaka Ueda; Tomomi Egawa-Takata; Yusuke Tanaka; Akiko Morimoto; Yoshito Terai; Masahide Ohmichi; Tomoyuki Ichimura; Toshiyuki Sumi; Hiromi Murata; Hidetaka Okada; Hidekatsu Nakai; Masaki Mandai; Kiyoshi Yoshino; Tadashi Kimura; Junko Saito; Risa Kudoh; Masayuki Sekine; Takayuki Enomoto; Kei Hirai; Yorihiko Horikoshi; Tetsu Takagi; Kentaro Shimura
Journal:  BMC Public Health       Date:  2016-09-23       Impact factor: 3.295

  6 in total
  3 in total

1.  Educational intervention for women in Japan coming of age for cervical cancer screening who grew up during the suspended HPV-vaccination-program.

Authors:  Ai Miyoshi; Yutaka Ueda; Asami Yagi; Toshihiro Kimura; Eiji Kobayashi; Kosuke Hiramatsu; Satoshi Nakagawa; Tadashi Kimura
Journal:  Hum Vaccin Immunother       Date:  2021-11-02       Impact factor: 3.452

2.  Examining Long-Term Effects of Human Papillomavirus Vaccine Recommendation Messages: A 4-Month Follow-Up Survey of a Randomized Controlled Study in Japan.

Authors:  Tsuyoshi Okuhara; Hirono Ishikawa; Haruka Ueno; Hiroko Okada; Takahiro Kiuchi
Journal:  Healthcare (Basel)       Date:  2020-12-10

3.  Opt-out policy and its improvements promote COVID-19 vaccinations.

Authors:  Xin Liu; Ning Zhao; Shu Li; Rui Zheng
Journal:  Soc Sci Med       Date:  2022-06-22       Impact factor: 5.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.